Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice

Neuropeptides

Volumn 37, Issue 1, 2003, Pages 36-44

  Gabra, Bichoy H ^a   Sirois, Pierre ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Bradykinin B1 receptors; DBK; Hyperalgesia; Insulin dependent diabetes mellitus; Kinins; R 715; R 954

Indexed keywords

ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; ACETYLORNITHYLBRADYKININ[5ALPHA METHYLPHENYLALANINE][7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; R 954; UNCLASSIFIED DRUG; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EVALUATION; HOMEOSTASIS; HYPERALGESIA; HYPERTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MALE; MOUSE; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RETINOPATHY; STREPTOZOCIN DIABETES; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; IMMERSION; METABOLISM; PAIN ASSESSMENT; REACTION TIME; STIMULATION;

ANIMALS; BLOOD GLUCOSE; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; IMMERSION; MALE; MICE; PAIN MEASUREMENT; PHYSICAL STIMULATION; REACTION TIME; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ;

EID: 0037305743     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(02)00148-8     Document Type: Article

References (49)

1. Bélichard, P., Landry, M., Faye, P., Bachvarov, D.R., Bouthillier, J., Pruneau, D., Marceau, F., 2000. Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists. Immunopharmacology 46, 139-147.
2. 5 enkephalin and morphine in the mouse. Neuropeptides 30, 219-223.
3. Bhoola, K.D., Figueroa, C.D., Worthy, K., 1992. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
4. Calixto, J.B., Cabrini, D.A., Ferreira, J., Campos, M.M., 2000. Kinins in pain and inflammation. Pain 87, 1-5.
5. 1 kinin receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways. Br. J. Pharmacol. 127, 1851-1859.
6. Chakir, M., Plante, G.E., 1996. Endothelial dysfunction in diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 54, 45-51.
7. 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br. J. Pharmacol. 130, 375-385.
8. Coderre, T.J., Rollman, G.B., 1983. Naloxone hyperalgesia and stress-induced analgesia in rats. Life Sci. 32, 2139-2146.
9. Couture, R., Harrisson, M., Vianna, R.M., Cloutier, F., 2001. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429, 161-176.
10. 9] BK: influence of enalaprilat. Am. J. Physiol. 270, H1340-H1347.
11. 9] BK in carrageenan-induced edema. Peptides 17, 1009-1015.
12. Dray, A., 1994. Tasting the inflammatory soup: the role of peripheral neurones. Pain Rev. 1, 153-171.
13. Dray, A., 1995. Inflammatory mediators of pain. Br. J. Anaesth. 75, 125-130.
14. Dray, A., 1997. Kinins and their receptors in hyperalgesia. Can. J. Physiol. Pharmacol. 75, 704-712.
15. Dray, A., Perkins, M.N., 1993. Bradykinin and inflammatory pain. Trends Neurosci. 16, 99-104.
16. Dray, A., Perkins, M.N., 1997. Kinins and pain. In: Farmer, S. (Ed.), The Kinin System. Academic Press, San Diego, pp. 157-172.
17. Dray, A., Patel, I.A., Perkins, M.N., Rueff, A., 1992. Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. Br. J. Pharmacol. 107, 1129-1134.
18. 2 kinin receptors to agonist stimulation. Immunopharmacology 45, 13-20.
19. 2 receptor knockout mice. Neuropharmacology 41, 1006-1012.
20. Hargreaves, K.M., Dubner, R., Brown, F., Flores, C., Joris, J., 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
21. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia. Pain 75, 169-176.
22. Katovich, M.J., Hanley, K., Strubbe, G., Wright, B.E., 1995. Effects of streptozotocin-induced diabetes and insulin treatment on blood pressure in the male rat. Proc. Soc. Exp. Biol. Med. 208, 300-306.
23. Levine, J.D., Fields, H.L., Basbaum, A.I., 1993. Peptides and the primary afferent nociceptor. J. Neurosci. 13, 2273-2286.
24. 2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 86, 265-271.
25. Lukić, M.L., Stosic-Grujicic, S., Shahin, A., 1998. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6, 119-128.
26. 1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can. J. Physiol. Pharmacol. 80, 328-333.
27. Marceau, F., Bachvarov, D.R., 1998. Kinin receptors. Clin. Rev. Allergy Immunol. 16, 385-401.
28. Marceau, F., Hess, J.F., Bachvarov, D.R., 1998. The B1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
29. McEvoy, R.C., Andersson, J., Sandler, S., Hellerstrom, C., 1984. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing β cell line. J. Clin. Invest. 74, 715-722.
30. 1 receptor antagonists with multi-enzymatic resistance properties. Can. J. Physiol. Pharmacol. 80, 287-292.
31. 8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain 53, 191-197.
32. 2 receptor mechanisms and cytokine-induced hyperalgesia in the rat. Can. J. Physiol. Pharmacol. 73, 832-836.
33. 1 receptors. Proc. Natl. Acad. Sci. USA 97, 8140-8145.
34. Petersen, M., Eckert, A.S., Segond von Banchet, G., Heppelmann, B., Klusch, A., Kniffki, K.D., 1998. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience 83, 949-959.
35. 1 in human lung fibroblasts. Mol. Pharmacol. 56, 325-333.
36. Pheng, L.H., Nguyen-Le, X.K., Nsa Allogho, S., Gobeil, F., Regoli, D., 1997. Kinin receptors in the diabetic mouse. Can. J. Physiol. Pharmacol. 75, 609-611.
37. Plante, G.E., Chakir, M., Ettaouil, K., Lehoux, S., Sirois, P., 1996. Consequences of alteration in capillary permeability. Can. J. Physiol. Pharmacol. 74, 824-833.
38. 2 receptors, tumour necrosis factor α and inflammatory hyperalgesia. Br. J. Pharmacol. 126, 649-656.
39. Rabinovitch, A., 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14, 129-151.
40. Regoli, D., Nsa Allogho, S., Rizzi, A., Gobeil, F., 1998. Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 348, 1-10.
41. Regoli, D., Rizzi, A., Perron, S.I., Gobeil, F., 2001. Classification of kinin receptors. Biol. Chem. 382, 31-35.
42. 2 receptor on nociception in rats and mice. Pain 71, 89-97.
43. 1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem. Biophys. Res. Commun. 243, 246-252.
44. Steil, C.F., 1999. Diabetes mellitus. In: Diprio, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Weels, B.G., Posey, L.M. (Eds.), Pharmacotherapy: A pathophysiological Approach. Appleton and Lange, Stamfort, CT, pp. 1219-1243.
45. Yerneni, K.K., Bai, W., Khan, B.V., Medford, R.M., Natarajan, R., 1999. Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 48, 855-864.
46. Walker, K., Perkins, M., Dray, A., 1995. Kinins and kinin receptors in the nervous system. Neurochem. Int. 26, 1-16.
47. Wilson, G.L., Leiter, E.H., 1990. Streptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes. Curr. Top. Microbiol. Immunol. 156, 27-54.
48. 2 kinin receptor antagonists in diabetic mice. Can. J. Physiol. Pharmacol. 74, 586-589.
49. Zuccollo, A., Navarro, M., Frontera, M., Cueva, F., Carattino, M., Catanzaro, O., 1999. The involvement of kallikrein-kinin system in diabetes type 1 (insulitis). Immunopharmacology 45, 69-74.